-
Something wrong with this record ?
Hereditary hyperferritinemia-cataract syndrome in three Czech families: molecular genetic testing and clinical implications
J. Moravikova, T. Honzik, E. Jadvidzakova, K. Zdrahalova, R. Kremlikova Pourova, M. Korbasova, P. Liskova, L. Dudakova
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NV17-30500A
MZ0
CEP Register
- MeSH
- Apoferritins genetics MeSH
- Hyperferritinemia * MeSH
- Cataract * diagnosis genetics MeSH
- Humans MeSH
- Molecular Biology MeSH
- Mutation MeSH
- Pedigree MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: Hereditary hyperferritinemia-cataract syndrome (HHCS) is an autosomal dominant disorder manifesting with high serum ferritin levels and the formation of early-onset cataracts, with numerous small opacities, predominantly in the lens cortex. HHCS is caused by mutations in the iron-responsive element of the FTL gene. The aim of this study was to establish a molecular diagnosis in three Czech probands with suspected HHCS. METHODS: A complex ocular and systemic evaluation, including ferritin and iron measurements, was performed. The 5' untranslated region of FTL was directly sequenced in all available family members, followed by paternity testing in one family. RESULTS: Three different FLT pathogenic variants (c.-161C>T, c.-167C>T, and c.-168G>C) present in the heterozygous state were detected in each of the 3 probands. Two segregated with the disease phenotype within the families, but c.-167C>T occurred de novo (confirmed by paternity testing). Prior to establishing molecular diagnosis, two probands were misdiagnosed with hemochromatosis. One individual, aged 43 years, underwent phlebotomy; another, aged 8.5 years, was treated with the iron chelator deferasirox, leading to life-threatening acute hyperammonemia, without severe liver injury. CONCLUSIONS: Lack of family history does not exclude HHCS, because the pathogenic variant can arise de novo. Noncoding regions are often omitted from diagnostic gene panels, thus evading detection. Careful clinical evaluations and targeted genetic screening are important for avoiding potentially harmful treatments.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026381
- 003
- CZ-PrNML
- 005
- 20211209092656.0
- 007
- ta
- 008
- 211013s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jaapos.2020.07.014 $2 doi
- 035 __
- $a (PubMed)33221470
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Moravikova, Jana $u Research Unit for Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 245 10
- $a Hereditary hyperferritinemia-cataract syndrome in three Czech families: molecular genetic testing and clinical implications / $c J. Moravikova, T. Honzik, E. Jadvidzakova, K. Zdrahalova, R. Kremlikova Pourova, M. Korbasova, P. Liskova, L. Dudakova
- 520 9_
- $a BACKGROUND: Hereditary hyperferritinemia-cataract syndrome (HHCS) is an autosomal dominant disorder manifesting with high serum ferritin levels and the formation of early-onset cataracts, with numerous small opacities, predominantly in the lens cortex. HHCS is caused by mutations in the iron-responsive element of the FTL gene. The aim of this study was to establish a molecular diagnosis in three Czech probands with suspected HHCS. METHODS: A complex ocular and systemic evaluation, including ferritin and iron measurements, was performed. The 5' untranslated region of FTL was directly sequenced in all available family members, followed by paternity testing in one family. RESULTS: Three different FLT pathogenic variants (c.-161C>T, c.-167C>T, and c.-168G>C) present in the heterozygous state were detected in each of the 3 probands. Two segregated with the disease phenotype within the families, but c.-167C>T occurred de novo (confirmed by paternity testing). Prior to establishing molecular diagnosis, two probands were misdiagnosed with hemochromatosis. One individual, aged 43 years, underwent phlebotomy; another, aged 8.5 years, was treated with the iron chelator deferasirox, leading to life-threatening acute hyperammonemia, without severe liver injury. CONCLUSIONS: Lack of family history does not exclude HHCS, because the pathogenic variant can arise de novo. Noncoding regions are often omitted from diagnostic gene panels, thus evading detection. Careful clinical evaluations and targeted genetic screening are important for avoiding potentially harmful treatments.
- 650 _2
- $a apoferritiny $x genetika $7 D001052
- 650 12
- $a katarakta $x diagnóza $x genetika $7 D002386
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hyperferritinemie $7 D000085583
- 650 _2
- $a molekulární biologie $7 D008967
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a rodokmen $7 D010375
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Honzik, Tomas $u Research Unit for Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Jadvidzakova, Eva $u Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Zdrahalova, Katerina $u Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Kremlíková Pourová, Radka, $u Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $d 1980- $7 xx0160300
- 700 1_
- $a Korbasova, Marta $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
- 700 1_
- $a Liskova, Petra $u Research Unit for Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
- 700 1_
- $a Dudakova, Lubica $u Research Unit for Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic. Electronic address: lubica.dudakova@lf1.cuni.cz
- 773 0_
- $w MED00007058 $t Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus $x 1528-3933 $g Roč. 24, č. 6 (2020), s. 352.e1-352.e5
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33221470 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211209092655 $b ABA008
- 999 __
- $a ok $b bmc $g 1715180 $s 1146888
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 24 $c 6 $d 352.e1-352.e5 $e 20201119 $i 1528-3933 $m Journal of AAPOS $n J AAPOS $x MED00007058
- GRA __
- $a NV17-30500A $p MZ0
- LZP __
- $a Pubmed-20211013